通痹冠脉丸治疗冠心病不稳定性心绞痛30例  

30 Cases with Unstable Angina Due to Coronary Heart Disease Treated with Tongbi Guanmai Pill

作　　者：安志红[1] 李晓东[1] 

机构地区：[1]唐山市丰润区中医医院,河北唐山064000

出　　处：《河南中医》2015年第4期734-735,共2页Henan Traditional Chinese Medicine

摘　　要：目的:观察通痹冠脉丸治疗不稳定心绞痛的临床疗效。方法:将60例冠心病不稳定性心绞痛患者随机分为对照组和治疗组各30例,对照组采用口服抗心绞痛药物(硝酸酯类、β受体阻滞剂或钙离子拮抗剂)及降脂、降压药等治疗,并同时应用低分子肝素钠,治疗组在对照组治疗的基础上加用通痹冠脉丸治疗,两组均以2周为1个疗程,观察两组临床疗效及相关指标。结果:对照组有效率为63.3%,治疗组有效率为86.7%,两组有效率比较,差异有显著性(P<0.05);治疗后两组CRP均较治疗前明显降低,组间比较差异显著(P<0.05)。结论:通痹冠脉丸治疗冠心病不稳定性心绞痛疗效显著。Objective： To observe the clinical effect of Tongbi Guanmai Pill on unstable angina due to coronaly heart disease （CHD）. Methods ：60 cases with unstable angina due to CHD were randomized into control group and treatment group, with 30 ca- ses in each group. Control group were orally given anti-angina drugs（ nitrates, β receptor blocker, or calcium ehaunel blocker） ,lip- id and blood pressure lowering drugs,and simuhaneously given Low-Molecular-Weight Heparin Sodium. On the basis of the treat- ment in control group, Treatment group were additionally given Tongbi Guamnai Pill, with 2 weeks as a treatment course. The clin- ical effects and relative indexes in the two groups were observed. Results：The effective rate of was 63.3% in control group and 86.7% in treatment group;the difference was statistically significant（ P 〈 0.05）. The CRP in both groups greatly declined after the treatment ;there was significant difference between the two groups （P 〈 0.05 ）. Conclusion. Tongbi Guanmai Pill on unstable angina due to CHD.

关 键 词：不稳定性心绞痛 冠心病 通痹冠脉丸 

分 类 号：R256.22[医药卫生—中医内科学]